Fallübersicht

Die Parteien

Das streitige Patent

The ‘185 patent covers formulations designed to inhibit ethylene-triggered ripening and senescence in harvested plant materials — a foundational technology class in the global fresh produce supply chain.

• • US 6,897,185 — Formulation for Counteracting an Ethylene Response in Plants, Preparation Process Thereof, and Method Using the Same. Claims 3 and 11 were at issue.

Das Urteil und die rechtliche Analyse

Ergebnis

The Federal Circuit issued a full affirmance of the PTAB’s IPR determination. The court’s ruling is direct: claims 3 and 11 of U.S. Patent No. 6,897,185 are unpatentable. The basis of termination is recorded as Invalidity/Cancellation Action, and the disposition is marked Unpatentable — meaning the challenged claims are cancelled and cannot be enforced.

No damages or injunctive relief are at issue, consistent with the IPR mechanism, which is an administrative validity proceeding rather than an infringement action.

Urteilsursachenanalyse

The Federal Circuit’s opinion addresses AgroFresh’s remaining arguments on appeal and explicitly finds them unpersuasive, affirming PTAB’s reasoning in IPR2021-00451 without reversal or remand on any contested point.

The verdict cause is classified under Patentability — Invalidity/Cancellation Action, indicating that the challenge centered on whether the ‘185 patent’s claims met the statutory requirements for patentability under 35 U.S.C. — most commonly obviousness (§ 103) or anticipation (§ 102) in IPR proceedings, which are limited to prior art-based grounds.

While the full opinion’s detailed claim-by-claim reasoning is not reproduced in available case data, the Federal Circuit’s unequivocal affirmance signals that PTAB’s evidentiary findings and legal conclusions were well-supported by the record. In IPR appellate review, PTAB findings of fact are reviewed for substantial evidence, a deferential standard that makes reversal on factual patentability determinations uncommon when the Board’s reasoning is clearly articulated.

Rechtliche Bedeutung

This ruling carries several layers of significance for agricultural biotechnology patent litigation:

1. IPR as a Viable Invalidity Tool: The successful cancellation of claims 3 and 11 via IPR — upheld on appeal — confirms the effectiveness of inter partes review for challenging formulation patents in the agrochemical space, even those held by well-resourced patent owners with experienced litigation counsel.
2. Appellate Deference to PTAB: The Federal Circuit’s rejection of all of AgroFresh’s remaining arguments reinforces the difficulty of overturning IPR invalidity determinations at the appellate level, particularly on prior art grounds.
3. Claim Scope Vulnerability: The targeted cancellation of specific dependent and independent claims (3 and 11) suggests focused prosecution history or prior art issues particular to those claim limitations — a pattern patent practitioners should examine when drafting post-harvest chemistry claims.